Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Lysophospholipid Receptor-GSK1842799
GSK1842799

Chemical Structure : GSK1842799

CAS No.: 1005407-76-0

GSK1842799 (GSK 1842799)

Catalog No.: PC-61604Not For Human Use, Lab Use Only.

GSK1842799 is a potent, selective, oral bioavailable S1P1 agonist with bind affinity of 0.52 nM.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    GSK1842799 is a potent, selective, oral bioavailable S1P1 agonist with bind affinity of 0.52 nM.
    GSK1842799 displays an excellent selectivity (>3,000-fold) for S1P1 over S1P3.
    GSK1842799 significantly reduces blood lymphocyte at 3 mg/kg, achieves efficacy equivalent to FTY720 in the mouse EAE model of MS.

    Physicochemical Properties

    M.Wt 431.518
    Formula C20H28F3N3O2S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (S)-2-amino-2-(5-(4-(octyloxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propan-1-ol

    References

    1. Deng H, et al. ACS Med Chem Lett. 2013 Aug 27;4(10):942-7.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: